Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/1998
12/03/1998WO1998039440A3 CALCIUM INDEPENDENT RECEPTOR OF α-LATROTOXIN, CHARACTERIZATION AND USES THEREOF
12/03/1998WO1998039427A3 Gene therapy using bone marrow transplants transfected with therapeutic genes under the control of tissue-specific promoters
12/03/1998WO1998038302A3 TETRODOTOXIN-SENSITIVE SODIUM CHANNEL α-SUBUNIT
12/03/1998WO1998036636A3 Method for generating embryogenic cell cultures for the production of bananas (musa spp.)
12/03/1998WO1998035027A3 Human nerve growth factor exon 1 and exon 3 promoters
12/03/1998WO1998033916A3 Secreted proteins and polynucleotides encoding them
12/03/1998DE4244915C2 Fungal cells contg. mutated DPM2 mannosyl transferase gene
12/03/1998DE19722888A1 Human-CD28 spezifische monoklonale Antikörper zur antigenunspezifischen Aktivierung von T-Lymphozyten Human CD28 specific monoclonal antibodies for the antigen non-specific activation of T-lymphocytes
12/03/1998DE19719652A1 Use of tissue factor
12/03/1998CA2358161A1 Organisms containing insecticidal proteins
12/03/1998CA2292790A1 Human tumor necrosis factor receptor tr10
12/03/1998CA2291960A1 Human type 3 ryanodine receptor protein and dna molecules coding therefor
12/03/1998CA2291881A1 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
12/03/1998CA2291861A1 Zinc finger protein derivatives and methods therefor
12/03/1998CA2291859A1 Cloning of udp-galactose epimerase
12/03/1998CA2291839A1 Conjugated peptide nucleic acids having enhanced cellular uptake
12/03/1998CA2291731A1 Prediction of inflammatory disease associated with il-1 gene loci polymorphisms
12/03/1998CA2291720A1 Pharmaceutical compositions comprising a soluble laminin receptor precursor of a compound which blocks the interaction of the laminin receptor precursor and prpsc or prpc
12/03/1998CA2291713A1 Methods for analyzing animal products
12/03/1998CA2291698A1 Osf2/cbfa1 compositions and methods of use
12/03/1998CA2291595A1 Dna methyltransferase genomic sequences and antisense oligonucleotides
12/03/1998CA2291590A1 Combined product associating a nucleic acid with a substance breaking up the extracellular matrix for gene therapy
12/03/1998CA2291516A1 Mammalian lysophosphatidic acid acyltransferase
12/03/1998CA2291512A1 Methods of making an rnp particle having nucleotide integrase activity
12/03/1998CA2291510A1 Modulators of morphogen expression and methods of identifying the same
12/03/1998CA2291484A1 Gene and amino acid sequences for novel transcription factor
12/03/1998CA2291482A1 Tissue plasminogen activator-like protease
12/03/1998CA2291451A1 Inhibition of stress activated protein kinase (sapk) pathway and sensitization of cells to cancer therapies
12/03/1998CA2291449A1 In vivo modification of galactomannans in guar by expression of udp-galactose epimerase antisense rna
12/03/1998CA2291323A1 Alternatively targeted adenovirus
12/03/1998CA2291278A1 Antigen delivery system
12/03/1998CA2291221A1 32 human secreted proteins
12/03/1998CA2291004A1 Immunological method
12/03/1998CA2290954A1 Human multiple endocrine neoplasia type 1 protein
12/03/1998CA2290943A1 New human dp1 homolog
12/03/1998CA2289905A1 Hypersensitive response elicitor fragments and uses thereof
12/03/1998CA2288967A1 Selective induction of cell death by delivery of amino-terminal interleukin-1-alpha pro-piece polypeptide
12/03/1998CA2288840A1 Integrin-targeting vectors having transfection activity
12/03/1998CA2288235A1 Tumour suppressor gene dbccr1 at 9q32-33
12/02/1998EP0881302A2 Detection of nucleic acids by fluorescence quenching
12/02/1998EP0881298A2 Metalloporoteases
12/02/1998EP0881297A2 Histidine kinase
12/02/1998EP0881296A2 Histidine kinase
12/02/1998EP0881295A2 Histidine kinase
12/02/1998EP0881294A2 HOEFCC11, a HAS2 splicing variant
12/02/1998EP0881292A2 Streptocococcus pneumoniae peptide release factor
12/02/1998EP0881291A2 CBS2 polypeptides, members of the guanine exchange factor family
12/02/1998EP0881290A2 Neurotransmitter transporter HPDDV78
12/02/1998EP0881289A2 Novel 7TM receptor (H2CAA71)
12/02/1998EP0881288A1 Purification of higher order transcription complexes from transgenic non-human animals
12/02/1998EP0881286A2 Histidine kinase
12/02/1998EP0881285A1 D-Alanine transferase
12/02/1998EP0880703A2 Method for the simultaneous detection of a therapeutic target for a disease state and its neutralizing antibody-like molecule
12/02/1998EP0880701A1 Methods of assessing mhc class i expression and proteins capable of modulating class i expression
12/02/1998EP0880597A1 THERAPEUTIC APPLICATIONS FOR THE ANTI-T-BAM (CD40-L) MONOCLONAL ANTIBODY 5c8
12/02/1998EP0880596A1 Receptor specific chimeric viral surface polypeptides for viral and particle incorporation and internalization in target cells
12/02/1998EP0880595A1 10a1 retroviral packaging cells and uses thereof
12/02/1998EP0880594A1 Retroviral vector and its use in gene therapy
12/02/1998EP0880593A1 Improvements in or relating to gene expression
12/02/1998EP0880592A2 Genetic transformation of trees
12/02/1998EP0880591A1 Thrombin muteins as antidotes for thrombin inhibitors
12/02/1998EP0880590A1 Esterases
12/02/1998EP0880589A2 Recombinant protein containing a c-terminal fragment of plasmodium msp-1
12/02/1998EP0880588A2 Recombinant protein containing a c-terminal fragment of plasmodium msp-1
12/02/1998EP0880587A1 Gene therapy method using fgf-5
12/02/1998EP0880586A1 Lyst1 and lyst2 gene compositions and methods of use
12/02/1998EP0880585A1 Method of plasmid dna production and purification
12/02/1998EP0880584A1 Cytokine expressed by dia/lif-deficient embryonic stem cells for the inhibition of differentiation
12/02/1998EP0880537A1 Isolation and amplification of nucleic acid materials
12/02/1998EP0880536A2 Process for preparing purified nucleic acid and the use thereof
12/02/1998EP0880535A1 Method and device for the simultaneous isolation of genomic dna and high-purity total rna
12/02/1998EP0880530A1 Phosphatidyl oligoglycerols
12/02/1998EP0880361A1 Immunogenic detoxified mutants of cholera toxin
12/02/1998EP0880360A1 Novel methods of vaccination and vaccines therefore comprising a nucleic acid encoding a first epitope and a peptide containing a second epitope
12/02/1998EP0880356A1 Antimicrobial peptides and methods of use
12/02/1998EP0880312A1 Plants having mutant sequences that confer altered fatty acid profiles
12/02/1998EP0869975A4 Assay for and uses of peptide hormone receptor ligands
12/02/1998EP0787206A4 USE OF NEURITE LOCALIZED mRNAs FOR MEDICAL DIAGNOSIS AND THERAPEUTICS
12/02/1998EP0784424A4 Cytoplasmic male sterility system producing canola hybrids
12/02/1998EP0771210A4 TWO NON-CONTIGUOUS REGIONS CONTRIBUTE TO NIDOGEN BINDING TO A SINGLE EGF-LIKE MOTIF OF THE LAMININ -g(g)1 CHAIN
12/02/1998EP0752875A4 Glioblastoma-derived angiogenesis inhibiting factor
12/02/1998EP0749581B1 Binding assay using binding agents with tail groups
12/02/1998EP0724650A4 Selection and use of antiviral peptides
12/02/1998EP0719265B1 Nucleoside derivatives, methods for the manufacture thereof and specific polyclonal and monoclonal antibodies of said derivatives
12/02/1998EP0652971A4 Gene detection system.
12/02/1998EP0599913B1 Monoclonal antibodies to putative hcv ns5 proteins and methos for using same
12/02/1998EP0542887B1 Psoralen conjugated methylphosphonate oligonucleotides as therapeutic agents for chronic myelogenous leukemia
12/02/1998EP0527839B1 Recombinant library screening methods
12/02/1998EP0527785B1 Improvements relating to the detection of viruses
12/02/1998CN1200767A Diagnostic method and kit for determining Rh blood group genotype
12/02/1998CN1200764A Process for preparing O-acetylsering, L-cysteine and L-cystein-related products
12/02/1998CN1200763A New adhesion from helicobactor pylori
12/02/1998CN1200737A Recombinant anti-CD4 antibodies for human therapy
12/02/1998CN1200404A Method of selection of Allelic exchange mutants
12/02/1998CN1200235A Purificn. of higher order transcription complexes from transgenic non-human animals
12/02/1998CA2230963A1 A human 7-tm receptor similar to murine frizzled-6 gene
12/02/1998CA2224407A1 Genes controlling floral development and apical dominance in plants
12/01/1998US5845028 Alignment assembly for multifiber or single fiber optical cable connector
12/01/1998US5844121 Method of inhibiting mycotoxin production in seed crops by modifying lipoxygenase pathway genes
12/01/1998US5844119 Genetically modified plants having modulated flower development
1 ... 3461 3462 3463 3464 3465 3466 3467 3468 3469 3470 3471 3472 3473 3474 3475 3476 3477 3478 3479 3480 3481 ... 4023